Abstract:Numerous studies have proved that cell-nonautonomous regulation of neoplastic cells is a distinctive and essential characteristic of tumorigenesis. Two way communications between the tumor and the stroma, or within the tumor significantly influence disease progression and modify treatment responses. In the tumor microenvironment (TME), malignant cells utilize paracrine signaling initiated by adjacent stromal cells to acquire resistance against multiple types of anticancer therapies, wherein extracellular vesicles (EVs) substantially promote such events. EVs are nanoscaled particles enclosed by phospholipid bilayers, and can mediate intercellular communications between cancerous cells and the adjacent microenvironment to accelerate pathological proceeding. Here we review the most recent studies of EV biology and focus on key cell lineages of the TME and their EV cargoes that are biologically active and responsible for cancer resistance, including proteins, RNAs, and other potentially essential components. Since EVs are emerging as novel but critical elements in establishing and maintaining hallmarks of human cancer, timely and insightful understanding of their molecular properties and functional mechanisms would pave the road for clinical diagnosis, prognosis, and effective targeting in the global landscape of precision medicine. Further, we address the potential of EVs as promising biomarkers in cancer clinics and summarize the technical improvements in EV preparation, analysis, and imaging. We highlight the practical issues that should be exercised with caution to guide the development of targeting agents and therapeutic methodologies to minimize cancer resistance driven by EVs, thereby allowing to effectively control the early steps of disease exacerbation.

Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment

Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment

Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy

Extracellular vesicles derived from immune cells: Role in tumor therapy

Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management

Extracellular Vesicles for Drug Delivery in Cancer Treatment

Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects

Harnessing the therapeutic potential of extracellular vesicles for cancer treatment

Extracellular Vesicles in Cancer Therapy: Roles, Potential Application, and Challenges

Engineered Extracellular Vesicles for Cancer Therapy

Extracellular Vesicles and Their Applications in Tumor Diagnostics and Immunotherapy

Extracellular Vesicles as Drug Delivery System for Cancer Therapy

Extracellular vesicles for cancer therapy: potential, progress, and clinical challenges

Extracellular vesicle-based drug delivery systems for cancer treatment

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles

Extracellular Vesicles in Cancer Metastasis: Potential as Therapeutic Targets and Materials

Challenges and Opportunities for Extracellular Vesicles in Clinical Oncology Therapy

Emerging Significance and Therapeutic Potential of Extracellular vesicles

Application of engineered extracellular vesicles for targeted tumor therapy

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies